Safety and Efficacy of Imeglimin for Type 2 Diabetes Mellitus in Patients With Heart Failure.
Nishikawa T, Higaki A, Kurokawa K, Yoshimoto K, Horie R, Nakao Y, Fujisawa T, Miyazaki S, Akazawa Y, Miyoshi T, Kawakami H, Higashi H, Tamaki S, Nishimura K, Inoue K, Ikeda S, Yamaguchi O.
Nishikawa T, et al.
In Vivo. 2025 Jan-Feb;39(1):375-380. doi: 10.21873/invivo.13838.
In Vivo. 2025.
PMID: 39740918
Free PMC article.